Comparing the effects of prescribed safer opioid supply and methadone in Ontario, Canada: a population-based matched cohort study
Gomes T, McCormack D, Kolla G, Young S, Bayoumi A, Smoke A, Li P, Antoniou T. Lancet Public Health. 2025; Apr 22.
Publications
Trends in the cost and utilization of publicly dispensed respiratory inhalers in Ontario, Canada: a repeated cross-sectional study
Garg R, Wang T, Tadrous M, Antoniou T, Gomes T. Pharmacoepidemiol Drug Saf. 2025; 34(4):e70125.
Systemic therapies for psoriatic disease and serious infections in older adults
Drucker AM, Sutradhar R, Ling V, Gatley JM, Eder L, Fahim C, Fralick M, Gomes T, Li P, MacDougall S, Manolson M, Rochon PA, Tadrous M. JAMA Dermatol. 2025; Mar 19 [Epub ahead of print].
Pathways of care following opioid overdose among people with opioid use disorder: a multilevel cohort study
Ledlie S, Tadrous M, Bayoumi AM, McCormack D, Besharah J, Munro C, Campbell T, Gomes T. Drug Alcohol Depend. 2025; Mar 8 [Epub ahead of print].
Global trends in analgesic opioid use in pregnancy: a retrospective cohort study
Brett J, Cesta CE, Gillies MB, Bateman BT, Chan A, Cheng M, Cho Y, Choi EY, Cohen JM, Donald S, Furu K, Gissler M, Gomes T, Havard A, Hernandez-Diaz S, Hsieh M, Huybrechts KF, Karlsson P, Kelty E, Lai E, Ledlie S, Wang T, Leinonen MK, Parkin L, Reutfors J, Shin JY, Su C, Varney B, Wong I, Man K, Zoega H. Anesthesiology. 2025; Feb 13 [Epub ahead of print].
Glucagon-like peptide 1 receptor agonists and risk of thyroid cancer: an international multisite cohort study
Baxter SM, Lund LC, Andersen JH, Brix TH, Hegedüs L, Hsieh MH, Su CT, Cheng MC, Chang ZC, Lai EC, Hussain S, Chu C, Gomes T, Antoniou T, Eskander A, Bouck Z, Tadrous M, Bea S, Choi EY, Shin JY, Modig K, Talbäck M, Ljung R, Gulseth HL, Karlstad Ø, Hicks B, Pottegård A. Thyroid. 2025; 35(1):69-78.
Impact of policy changes expanding access to direct-acting antivirals on hepatitis c virus-related hospitalizations in people with HIV: a population-based study
Antoniou T, Ledlie S, Wang T, Tadrous M, Gomes T. Open Forum Infect Dis. 2025; 12(1):ofaf003.
Maternal chronic physical conditions and alcohol and substance use disorders in the preconception and perinatal periods
Brown HK, Gomes T, Wilton AS, Camden A, Guttmann A, Dennis CL, Ray JG, Vigod SN. J Womens Health (Larchmt). 2025; Jan 10 [Epub ahead of print].
Trends, characteristics, and circumstances surrounding stimulant toxicity deaths in Ontario, Canada from 2018 to 2021
Ledlie S, Leece P, Yang J, Iacono A, Kolla G, Boyd R, Bozinoff N, Franklyn M, Shearer D, Smoke A, Wu F, Gomes T. J Subst Use Addict Treat. 2024; Dec 21 [Epub ahead of print].
Trends in injectable buprenorphine prescribing in Canada: a descriptive analysis in five Canadian provinces
Boilard P, Wang T, Iacono A, Ghosh SM, Gomes T. 2024; Sep 24 [Epub ahead of print. PMID: 39341014].